Skip to main content
. 2017 Aug 17;66(1):72–80. doi: 10.1093/cid/cix726

Figure 3.

Figure 3.

Cost impact of changing 2 model assumptions in a typical phase 3 hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia trial.